{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:02Z","timestamp":1791644582224,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Laboratories Thea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12325-019-01137-8","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T19:02:41Z","timestamp":1574103761000},"page":"329-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Topical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial"],"prefix":"10.1007","volume":"37","author":[{"given":"Martin","family":"Kallab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Hommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semira","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 M.","family":"Werkmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Schmidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Schmetterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Garh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"1137_CR1","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp MA. Report of the national eye institute\/industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221\u201332.","journal-title":"CLAO J"},{"key":"1137_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ajo.2008.05.016","volume":"146","author":"MA Lemp","year":"2008","unstructured":"Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol. 2008;146:350\u20136.","journal-title":"Am J Ophthalmol"},{"key":"1137_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438\u2013510.","journal-title":"Ocul Surf"},{"key":"1137_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276\u201383.","journal-title":"Ocul Surf"},{"key":"1137_CR5","doi-asserted-by":"publisher","first-page":"194848","DOI":"10.1100\/2012\/194848","volume":"2012","author":"B Yavuz","year":"2012","unstructured":"Yavuz B, Bozdag Pehlivan S, Unlu N. An overview on dry eye treatment: approaches for cyclosporin a delivery. Sci World J. 2012;2012:194848.","journal-title":"Sci World J"},{"key":"1137_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15:575\u2013628.","journal-title":"Ocul Surf"},{"key":"1137_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1755-3768.2011.02272.x","volume":"90","author":"BP Bielory","year":"2012","unstructured":"Bielory BP, O\u2019Brien TP, Bielory L. Management of seasonal allergic conjunctivitis: guide to therapy. Acta Ophthalmol. 2012;90:399\u2013407.","journal-title":"Acta Ophthalmol"},{"key":"1137_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0275-5408(97)00066-5","volume":"18","author":"N Efron","year":"1998","unstructured":"Efron N. Grading scales for contact lens complications. Ophthalmic Physiol Opt. 1998;18:182\u20136.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1137_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615\u201321.","journal-title":"Arch Ophthalmol"},{"key":"1137_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1542-0124(12)70083-6","volume":"5","author":"DEWS","year":"2007","unstructured":"DEWS. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:108\u201352.","journal-title":"Ocul Surf"},{"key":"1137_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640\u201350.","journal-title":"Cornea"},{"key":"1137_CR12","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1167\/iovs.13-11920","volume":"54","author":"RM Werkmeister","year":"2013","unstructured":"Werkmeister RM, Alex A, Kaya S, et al. Measurement of tear film thickness using ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54:5578\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1137_CR13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2147\/OPTH.S135068","volume":"11","author":"J Nolfi","year":"2017","unstructured":"Nolfi J, Caffery B. Randomized comparison of in vivo performance of two point-of-care tear film osmometers. Clin Ophthalmol. 2017;11:945\u201350.","journal-title":"Clin Ophthalmol"},{"key":"1137_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/bjo.2011.202754","volume":"96","author":"S Khanal","year":"2012","unstructured":"Khanal S, Millar TJ. Barriers to clinical uptake of tear osmolarity measurements. Br J Ophthalmol. 2012;96:341\u20134.","journal-title":"Br J Ophthalmol"},{"key":"1137_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0006-2952(97)00018-X","volume":"53","author":"M Goppelt-Struebe","year":"1997","unstructured":"Goppelt-Struebe M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem Pharmacol. 1997;53:1389\u201395.","journal-title":"Biochem Pharmacol"},{"key":"1137_CR16","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1111\/aos.13342","volume":"95","author":"PA Wozniak","year":"2017","unstructured":"Wozniak PA, Schmidl D, Bata AM, et al. Effect of different lubricant eye gels on tear film thickness as measured with ultrahigh-resolution optical coherence tomography. Acta Ophthalmol. 2017;95:e307\u201313.","journal-title":"Acta Ophthalmol"},{"key":"1137_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/ICO.0000000000000358","volume":"34","author":"D Schmidl","year":"2015","unstructured":"Schmidl D, Schmetterer L, Witkowska KJ, et al. Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease. Cornea. 2015;34:421\u20136.","journal-title":"Cornea"},{"key":"1137_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/jop.2016.0123","volume":"33","author":"D Schmidl","year":"2017","unstructured":"Schmidl D, Werkmeister R, Kaya S, et al. A controlled, randomized double-blind study to evaluate the safety and efficacy of chitosan-N-acetylcysteine for the treatment of dry eye syndrome. J Ocul Pharmacol Ther. 2017;33:375\u201382.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1137_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/aos.12647","volume":"93","author":"S Kaya","year":"2015","unstructured":"Kaya S, Schmidl D, Schmetterer L, et al. Effect of hyaluronic acid on tear film thickness as assessed with ultra-high resolution optical coherence tomography. Acta Ophthalmol. 2015;93:439\u201343.","journal-title":"Acta Ophthalmol"},{"key":"1137_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1167\/iovs.14-15814","volume":"56","author":"D Schmidl","year":"2015","unstructured":"Schmidl D, Witkowska KJ, Kaya S, et al. The association between subjective and objective parameters for the assessment of dry-eye syndrome. Invest Ophthalmol Vis Sci. 2015;56:1467\u201372.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1137_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/jop.2006.0091","volume":"23","author":"S Hong","year":"2007","unstructured":"Hong S, Kim T, Chung SH, Kim EK, Seo KY. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren\u2019s syndrome. J Ocul Pharmacol Ther. 2007;23:78\u201382.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1137_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00006324-200206000-00009","volume":"79","author":"JJ Nichols","year":"2002","unstructured":"Nichols JJ, Nichols KK, Puent B, Saracino M, Mitchell GL. Evaluation of tear film interference patterns and measures of tear break-up time. Optom Vis Sci. 2002;79:363\u20139.","journal-title":"Optom Vis Sci"},{"key":"1137_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/aos.12012","volume":"92","author":"BD Sullivan","year":"2014","unstructured":"Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92:161\u20136.","journal-title":"Acta Ophthalmol"},{"key":"1137_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/jop.2016.0105","volume":"33","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder SC, Stern M, Zhang S, Shojaei A. LFA-1\/ICAM-1 Interaction as a therapeutic target in dry eye disease. J Ocul Pharmacol Ther. 2017;33:5\u201312.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1137_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5301\/ejo.5000229","volume":"23","author":"P Aragona","year":"2013","unstructured":"Aragona P, Spinella R, Rania L, et al. Safety and efficacy of 01% clobetasone butyrate eyedrops in the treatment of dry eye in Sjogren syndrome. Eur J Ophthalmol. 2013;23:368\u201376.","journal-title":"Eur J Ophthalmol"},{"key":"1137_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5301\/ejo.5000779","volume":"26","author":"A Leonardi","year":"2016","unstructured":"Leonardi A, Van Setten G, Amrane M, et al. Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial. Eur J Ophthalmol. 2016;26:287\u201396.","journal-title":"Eur J Ophthalmol"},{"key":"1137_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","volume":"83","author":"CS De Paiva","year":"2006","unstructured":"De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006;83:526\u201335.","journal-title":"Exp Eye Res"},{"key":"1137_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.ico.0000240079.24583.a1","volume":"26","author":"K Lekhanont","year":"2007","unstructured":"Lekhanont K, Leyngold IM, Suwan-Apichon O, Rangsin R, Chuck RS. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model. Cornea. 2007;26:84\u20139.","journal-title":"Cornea"},{"key":"1137_CR29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","volume":"106","author":"P Marsh","year":"1999","unstructured":"Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology. 1999;106:811\u20136.","journal-title":"Ophthalmology"},{"key":"1137_CR30","first-page":"751","volume":"75","author":"MD Sainz","year":"2000","unstructured":"Sainz MD, Simon Castellvi C, Kabbani O. Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca. Arch Soc Esp Oftalmol. 2000;75:751\u20136.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"1137_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","volume":"138","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138:444\u201357.","journal-title":"Am J Ophthalmol"},{"key":"1137_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2005.09.033","volume":"113","author":"HK Lee","year":"2006","unstructured":"Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Ophthalmology. 2006;113:198\u2013205.","journal-title":"Ophthalmology"},{"key":"1137_CR33","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ophtha.2014.11.006","volume":"122","author":"A Kheirkhah","year":"2015","unstructured":"Kheirkhah A, Dohlman TH, Amparo F, et al. Effects of corneal nerve density on the response to treatment in dry eye disease. Ophthalmology. 2015;122:662\u20138.","journal-title":"Ophthalmology"},{"key":"1137_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2015.09.029","volume":"123","author":"J Pinto-Fraga","year":"2016","unstructured":"Pinto-Fraga J, Lopez-Miguel A, Gonzalez-Garcia MJ, et al. Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial. Ophthalmology. 2016;123:141\u201353.","journal-title":"Ophthalmology"},{"key":"1137_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12325-016-0315-8","volume":"33","author":"JD Sheppard","year":"2016","unstructured":"Sheppard JD, Comstock TL, Cavet ME. Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure. Adv Ther. 2016;33:532\u201352.","journal-title":"Adv Ther"},{"key":"1137_CR36","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1097\/OPX.0000000000000673","volume":"92","author":"M Teson","year":"2015","unstructured":"Teson M, Lopez-Miguel A, Neves H, Calonge M, Gonzalez-Garcia MJ, Gonzalez-Meijome JM. Influence of climate on clinical diagnostic dry eye tests: pilot study. Optom Vis Sci. 2015;92:e284\u20139.","journal-title":"Optom Vis Sci"}],"updated-by":[{"DOI":"10.1007\/s12325-019-01190-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01137-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:07:36Z","timestamp":1605571656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01137-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12325-019-01190-3","asserted-by":"object"}]},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]},"assertion":[{"value":"17 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article \u201cTopical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial\u201d, written by Martin Kallab, Stephan Szegedi, Nikolaus Hommer, Hannes Stegmann, Semira Kaya, Ren\u00e9 M. Werkmeister, Doreen Schmidl, Leopold Schmetterer, Gerhard Garh\u00f6fer was originally published electronically on the publisher\u2019s internet portal (currently SpringerLink) on November 19, 2019 without open access.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}